Test Catalog Search Results
PDSU - Overview: Drug Screen, Prescription/Over the Counter, Random, Urine
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is not...
GABA - Overview: Gabapentin, Serum
Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients
GD65C - Overview: Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid
Possible use in evaluating patients with autoimmune encephalitis, stiff-person syndrome, autoimmune ataxia, autoimmune epilepsy, and other acquired central nervous system disorders affecting gabaminergic neurotransmission
FRUCT - Overview: Fructosamine, Serum
Monitoring intermediate (1-3 weeks) glycemic control Monitoring glycemic control in patients with shortened red blood cell survival
DESPR - Overview: Desipramine, Serum
Monitoring serum concentration of desipramine during therapy Evaluating potential desipramine toxicity May aid in evaluating patient compliance
DLAC - Overview: D-Lactate, Plasma
As an adjunct to urine D-lactate (preferred) for the diagnosis of D-lactate acidosis
FXIII - Overview: Factor XIII (13), Screen, Plasma
Screening for factor XIII deficiency
RKUR - Overview: Potassium, Random, Urine
Determining the cause for hyper- or hypokalemia using a random urine specimen
NCDCC - Overview: Neurochondrin Antibody, Cell-Binding Assay, Spinal Fluid
Evaluating neurochondrin-IgG by cell-binding assay using spinal fluid from patients presenting with cerebellar and brainstem syndrome
PDETC - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence Titer, Spinal Fluid
Reporting an end titer result from phosphodiesterase 10A (PDE10A) in spinal fluid specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
PDEIS - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence, Serum
Detecting phosphodiesterase 10A (PDE10A)-IgG in serum specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
PDEIC - Overview: Phosphodiesterase 10A (PDE10A) IgG, Tissue Immunofluorescence, Spinal Fluid
Detecting phosphodiesterase 10A (PDE10A)-IgG in cerebrospinal fluid specimens Evaluation of autoimmune/paraneoplastic neurological syndromes among patients presenting with movement disorders and encephalopathy
NOTRP - Overview: Nortriptyline, Serum
Monitoring nortriptyline concentration during therapy Evaluating potential nortriptyline toxicity May aid in evaluating patient compliance
PLA2I - Overview: Phospholipase A2 Receptor, Immunofluorescence, Serum
Distinguishing primary from secondary membranous nephropathy in patients with low levels of anti-phospholipase A2 receptor (PLA2R) antibodies Screening for anti-PLA2R antibodies Monitoring patients with membranous nephropathy at very...
PBR - Overview: Phenobarbital, Serum
Monitoring for appropriate therapeutic concentration of phenobarbital Assessing compliance or toxicity
PNYF - Overview: Phenytoin, Free, Serum
Monitoring for appropriate therapeutic concentration of free phenytoin: free phenytoin level is the best indicator of adequate therapy in renal failure Assessing compliance and toxicity
NCDTS - Overview: Neurochondrin Antibody, Tissue Immunofluorescence Titer, Serum
Detecting neurochondrin-IgG in serum from patients presenting with cerebellar and brainstem syndrome Reporting an end titer result from serum specimens
EURO - Overview: Phospholipase A2 Receptor, Enzyme Linked Immunosorbent Assay, Serum
Distinguishing primary from secondary membranous nephropathy
ROC - Overview: Rubeola (Measles) Antibodies, IgG and IgM, Spinal Fluid
Diagnosing central nervous system rubeola (measles) virus infection and/or subacute sclerosing panencephalitis
UPHB - Overview: pH, Body Fluid
Indicating the presence of infections or fistulas Verifying the effectiveness of treatment to reduce stomach pH Diagnosing disease states characterized by abnormal stomach acidity This test is not appropriate for measurement of...
PA - Overview: Procainamide and N-Acetylprocainamide, Serum
Monitoring therapy with procainamide Assessing compliance Evaluating procainamide toxicity
SPNC - Overview: Streptococcus pneumoniae Antigen, Spinal Fluid
Rapid diagnosis of pneumococcal meningitis
SP7TS - Overview: Septin-7 Antibody, Tissue Immunofluorescence Titer, Serum
Detecting septin-7 IgG in serum specimens Reporting an end titer result from serum specimens
AATHI - Overview: Thrombophilia Profile Interpretation
Interpretation of testing performed as part of a profile to evaluate patients with thrombosis or hypercoagulability states including detecting a lupus-like anticoagulant; dysfibrinogenemia; disseminated intravascular...
HGCU - Overview: Mercury/Creatinine Ratio, Random, Urine
Detecting mercury toxicity using random urine specimens
TRCNG - Overview: Trichinella Antibody, IgG, Serum
As an adjunct in the diagnosis of trichinosis
DIA - Overview: Diazepam and Metabolites, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
THSD7 - Overview: Thrombospondin Type-1 Domain-Containing 7A Antibodies, Serum
Distinguishing primary from secondary membranous nephropathy cases with antibodies against THSD7A
RAMIK - Overview: Amikacin, Random, Serum
Monitoring adequacy of blood concentration during amikacin therapy
PAMIK - Overview: Amikacin, Peak, Serum
Monitoring adequacy of serum concentration during amikacin therapy
TAMIK - Overview: Amikacin, Trough, Serum
Monitoring adequate clearance of amikacin near the end of a dosing cycle
A1AF - Overview: Alpha-1-Antitrypsin, Random, Feces
Diagnosing protein-losing enteropathies, especially when used in conjunction with serum alpha-1-antitrypsin (AAT) levels as a part of AAT clearance studies
HSTNI - Overview: Troponin I, High Sensitivity, Plasma
Excluding the diagnosis of acute coronary syndromes Explaining troponin T elevations related to skeletal myopathy and/or assay interferences
TRMP - Overview: Trimipramine, Serum
Monitoring trimipramine concentration during therapy Evaluating potential trimipramine toxicity May aid in evaluating patient compliance
TRAM - Overview: Tramadol and Metabolite, Random, Urine
Monitoring of compliance utilizing tramadol Detection and confirmation of the illicit use of tramadol This test is not intended for use in employment-related testing.
TOBRA - Overview: Tobramycin, Random, Serum
Monitoring adequacy of serum concentration during tobramycin therapy This unit code is used whenever a specimen is submitted or collected without collection timing information. The phlebotomist should use this unit code if she or he does...
SASP - Overview: Aspergillus fumigatus, IgG Antibodies, Serum
Evaluation of patients suspected of having hypersensitivity pneumonitis (HP) induced by exposure to Aspergillus fumigatus Evaluation of patients suspected of having HP who have documented environmental exposures to high-humidity...
APBTS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Tissue Immunofluorescence Titer, Serum
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Reporting an end titer result from serum specimens
F_12 - Overview: Coagulation Factor XII Activity Assay, Plasma
Diagnosing deficiency of coagulation factor XII Determining cause of prolonged activated partial thromboplastin time
CLU - Overview: Chloride, 24 Hour, Urine
Indication of fluid balance and acid-base homeostasis using a 24-hour urine collection
BRUTA - Overview: Brucella Total Antibody Confirmation, Agglutination, Serum
Diagnosis of brucellosis
BARBU - Overview: Barbiturates Confirmation, Random, Urine
Detecting drug abuse involving barbiturates such as amobarbital, butalbital, pentobarbital, phenobarbital, and secobarbital
Interpretation for CIDP / Chronic Inflammatory Demyelinating Polyradiculoneuropathy/Nodopathy Evaluation, Serum
F8IS - Overview: Coagulation Factor VIII Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor VIII
CDP - Overview: Chlordiazepoxide and Metabolites, Serum
Monitoring chlordiazepoxide therapy Assessing toxicity
CRE2 - Overview: Creatinine, Urine
Normalization of urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
KCSF - Overview: Immunoglobulin Kappa Free Light Chain, Spinal Fluid
Diagnosing multiple sclerosis and other demyelinating conditions Evaluating patients who present with a clinically isolated syndrome in which the patient reports symptoms (headaches, optic neuritis, fatigue, and many others, depending on...
Simultaneous detection of influenza A virus, influenza B virus, and respiratory syncytial virus in upper or lower respiratory tract specimens from individuals with flu-like illnesses
HBAGQ - Overview: Hepatitis B Virus Surface Antigen, Quantitative, Serum
Monitoring of progression of chronic hepatitis B in individuals who are confirmed to be positive for hepatitis B surface antigen Monitoring of response to antiviral therapy in individuals who have chronic hepatitis B but are negative for...
F822B - Overview: Hemophilia A F8 Gene, Intron 22 Inversion Known Mutation, Whole Blood
First-tier molecular testing for male patients affected with severe hemophilia A, when a familial intron 22 inversion has been previously identified Determining hemophilia A carrier status for at-risk female patients, ie, individuals with...